![]() ChemoCentryx ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer. | ![]() Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. | NATCO Pharma NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). | |
Founding Date | Founding Date 1997 | Founding Date 2008 | Founding Date 1981 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations San Carlos, US HQ | Locations Cambridge, US HQ | Locations Hyderabad, IN HQ Central Hope Town, IN Chennai, IN Hyderabad, IN Santola, IN Vijayapuri North, IN |
Employees | Employees 51 | Employees 53611% increase | Employees 4,016 |
Financial | |||
Revenue (est.) | Revenue (est.) $32.2m (FY, 2021) | Revenue (est.) $54m (FY, 2025) | Revenue (est.) ₹44.1b (FY, 2025) |
Cost of goods | Cost of goods $302k (FY, 2021) | Cost of goods $6.3m (FY, 2025) | Cost of goods ₹7.5b (FY, 2025) |
Gross profit | Gross profit $31.9m (FY, 2021) | Gross profit $47.7m (FY, 2025) | Gross profit ₹37b (FY, 2025) |
Net income | Net income ($131.8m) (FY, 2021) | Net income ($412.8m) (FY, 2025) | Net income ₹18.8b (FY, 2025) |

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View companyNATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
View company